PTN - PALATIN TECHNOLOGIES INC
22.11
-0.335 -1.515%
Share volume: 18,002
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$22.44
-0.34
-0.01%
View ratios
| Fiscal Date | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2024 | Q2 2025 | Q1 2026 | Q2 2026 | |
| Report Date | 02-14-2024 | 05-15-2024 | 01-07-2025 | 11-14-2024 | 02-13-2025 | 11-14-2025 | 02-17-2026 | |
| Assets | ||||||||
| Total Assets | 13.555 M | 11.406 M | 10.742 M | 3.415 M | 4.310 M | 8.615 M | 17.928 M | |
| Current Assets | 12.245 M | 10.269 M | 9.770 M | 2.613 M | 3.670 M | 8.370 M | 17.467 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 9.485 M | 10.014 M | 9.527 M | 2.384 M | 3.417 M | 1.273 M | 14.476 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 550.465 K | 465.410 K | 388.361 K | 307.571 K | 235.741 K | 115.057 K | 113.485 K | |
| Other Assets | 758.919 K | 672.185 K | 584.237 K | 495.039 K | 404.560 K | 129.825 K | 346.764 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 13.555 M | 11.406 M | 10.742 M | 3.415 M | 4.310 M | 8.615 M | 17.928 M | |
| Total liabilities | 24.516 M | 9.827 M | 10.854 M | 11.101 M | 10.691 M | 8.218 M | 6.462 M | |
| Total current liabilities | 11.199 M | 8.533 M | 9.658 M | 9.862 M | 9.559 M | 8.218 M | 6.333 M | |
| Accounts Payable | 1.593 M | 3.443 M | 4.102 M | 3.949 M | 6.718 M | 7.406 M | 5.453 M | |
| Other liabilities | 12.633 M | 262.220 K | 163.782 K | 132.447 K | 100.071 K | 0.000 | 129.061 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 1.107 M | 1.032 M | 1.032 M | 1.107 M | 1.032 M | 0.000 | 0.000 | |
| Other liabilities | 12.633 M | 262.220 K | 163.782 K | 132.447 K | 100.071 K | 0.000 | 129.061 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -11.384 M | 1.579 M | -111.537 K | -7.686 M | -6.381 M | 396.325 K | 11.466 M | |
| Common stock | 413.696 M | 435.095 M | 441.655 M | 441.905 M | 445.652 M | 454.793 M | 473.126 M | |
| Retained earnings | -425.080 M | -433.516 M | -441.767 M | -449.590 M | -452.033 M | -454.396 M | -461.660 M |